TORR RF IP Portfolio

BRITZMEDI Intellectual Property — Core Patents & Regulatory Certifications

Core Patents (2)

Skin Care Device

Ref. No.: DP20-2116
Filing Date: 2020-10-29
Applicant: K Inc. (now BRITZMEDI)
Type: Patent9 Claims

A handpiece device that maximizes skin beautification without burn risk through a triple mechanism: RF electricity + eccentric rotation (rubbing) + vibration (tapping).

10-2597447

RF Thermo-Therapy Treatment Device

TREATMENT DEVICE FOR THERMO-THERAPY BY RADIO-FREQUENCY

Ref. No.: DP21-3104
Filing Date: 2021-02-19
Applicant: K Inc. (now BRITZMEDI)
Type: Patent6 Claims

Controls deep heat penetration depth by changing bipolar electrode pair positions — providing both skin beautification mode (shallow dermis) and body fat reduction mode (deep dermis) in a single device.

Certifications (1)

제허 22-156

KFDA Manufacturing License

MFDS Medical Device Manufacturing License — MTX-C1

Product: TORR RF (MTX-C1)
Validity: 2022.03.08 ~ 2027.03.07
Classification: Class 3 (A35010.01)
Type: KFDA22 Pages

MFDS (Korea FDA) Manufacturing License for general electrosurgical unit TORR RF MTX-C1, including working principle, exterior design, components, electrical characteristics, and usage instructions.

FDA Certifications (3)

K212561

510(k) Clearance Letter

Substantial Equivalence Determination — MTX-C1

Product: MTX-C1 (TORR RF)
Decision Date: 2022.09.27
Classification: Class II (21 CFR 878.4400)
Type: FDA8 Pages

FDA 510(k) clearance letter confirming MTX-C1 is substantially equivalent to predicate device Venus Legacy CX (K143554). Includes indications for use, device description, and performance data.

Est. 3029916132

Establishment Registration & Device Listing

FDA Registered Establishment — BRITZMEDI CO., LTD

Proprietary Name: ToRR
Product Code: GEI
Owner/Operator: Britzmedi Co., Ltd
Type: FDA2 Pages

FDA establishment registration confirming BRITZMEDI CO., LTD as a registered facility (No. 3029916132) with ToRR device listing under product code GEI, Class 2.

K212561

510(k) Premarket Notification

510(k) Database Record — MTX-C1 SESE Decision

Applicant: ILOODA Co., Ltd
Received: 2021.08.13
Decision: SESE (Substantially Equivalent)
Type: FDA3 Pages

Official FDA 510(k) premarket notification database record for MTX-C1. Confirms device classification, review panel assignment, and substantially equivalent decision.